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Cow milk casein consists of several fractions each of which have different structure and differing antigenicity. The aim of the study was to investigate the capacity of cow milk casein, casein fractions, casein hydrolysate and its fractions to bind human IgG antibodies (antigenicity).
Whole cow milk, bovine casein, α-casein native and dephosphorylated, β-and κ-casein, further a casein hydrolysate and its fractions were incubated in a IgG-ELISA assay with sera from five patients with cow milk intolerance and a pooled control serum from milk drinking healthy individuals.
In healthy controls, predominantly β-caseins, both commercial and chromatographically separated, contained the strongest antigenic epitopes. In milk intolerant infants, however, κ -casein along with β-caseins was the strongest antigen. The antigenicity of the casein hydrolysate compared to nonhydrolysed casein was reduced down to 18.5 and 41.8% measured with patient and control sera, respectively. There were traces of intact protein in the hydrolysate. Antigenicity of the casein hydrolysate fractions reached only 24 to 44% of the antigenicity of the whole hydrolysate. Although their antigenicity roughly correlated with their molecular weight, only negligible differences among particular fractions were found.
Cow milk beta-casein is the strongest antigen in healthy controls while kappa-casein possesses the high antigenicity in the milk intolerant individuals. For milk intolerant individuals, the tested casein hydrolysate was approximately 5 times less antigenic compared to whole casein. Antigenicity of the hydrolysate fractions were lower than that of the whole hydrolysate. Identification of cow milk caseins and its fractions with the highest bindnig capacity for human IgG antibodies is important for manufacturing of antigen-reduced formulas based on casein hydrolysates.
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Cow milk proteins belong to the strongest antigens in human diet. Caseins, representing about 80% of all cow milk proteins (Eigel et al. 1984) , have a fibrilar structure consisting of mainly sequential epitopes able to bind to specific IgG antibodies. Antigenic reactivity of a protein refers to its capacity to bind specifically to the functional binding sites or paratopes of certain immunoglobulin molecules (van Regenmortel 1988) . This is different among proteins due to the manifold quality and quantity of their specific epitopes. Using heat treatment and/or enzymatic hydrolysis, a reduction of the binding capacity of the proteins can be achieved. To study antigenicity of cow milk proteins and protein fragments sera from immunized animals on one hand and from sensitized human individuals on the other hand, can be used (Otani 1989; Otani et al. 1989) . Comparing antigenicity of casein hydrolysate to that of raw casein gives information on the efficacy of hydrolysis performed. Assessment of antigenicity of particular casein hydrolysate fractions indicates the extent of hydrolysis necessary for efficient antigenicity reduction of the hydrolysate.
In the present study we investigated the antigenicity of cow milk caseins: whole casein, α-casein, α-casein after dephosphorylation, β-and κ-casein. The difference in antigenicity between casein hydrolysate, whole cow milk and intact casein was further evaluated. Finally, residual antigenicity of casein hydrolysate peptide fractions together with their molecular weights were assessed.
Materials and Methods
Patient and control sera Sera from 5 patients (4 children, 1 adult) sufferring from adverse reactions to cow milk (vomiting, diarrhea, abdominal colic, skin symptoms) were used. A sample of venous blood was drawn from each patient and let clot. After centifugation, the serum was sampled and frozen at -20 °C until analysis. The sera were analysed within 2 months from sampling.
Controls
The same procedure was applied to obtain control sera. As controls, 4 adult individuals regularly drinking cow milk and showing no symptoms of milk intolerance were used. The sera were fused together to obtain a pooled control serum.
Antigens
An overview of antigens tested is given in Table 1 .
Fresh non-heated low-fat cow milk was obtained from a dairy. Cow milk was defatted three times by centrifugation for 10 minutes at 300 g. The whole casein from cow milk was purchased from Sigma (St. Louis, USA) as well as the β-casein designed as B-casein-S (Sigma). The whole casein, casein hydrolysate as well as all casein fractions were not pretreated.
Isolation of other casein fractions (α-casein, α-casein dephosphorylated, β-casein and κ-casein) is decribed elsewhere (Spuergin et al. 1996; Spuergin et al. 1997) . Briefly, the commercially available bovine casein (C7891, Sigma) was purified by anion exchange chromatography by means of the High-Load System (Pharmacia). An amount of 300 mg casein was dissolved in 4.0 ml of buffer A (Tris/HCl 20 mmol/l, pH 7.0; 4 mol/l urea and 10 mmol/l 2-mercaptoethanol) and applied onto a Sepharose FastFlow column equilibrated with the same buffer. Caseins were eluted at a flow rate of 1.0 ml/min with a gradient of 0-350 mmol NaCl in buffer A in 100 min, followed by a 20-min wash with 350 mmol NaCl, a second gradient of 350-500 mmol NaCl in 10 min and a final 20-min wash with 500 mmol NaCl. Eluted proteins were detected by absorption at 280 nm (Uvicord SII, Pharmacia). Pooled fractions were desalted and lyophilized. The purity and identitiy of caseins were checked by SDS-PAGE and by N-terminal amino-acid sequencing with a gas-phase sequencer (Protein Sequencer, Applied Biosystems). The casein hydrolysate was kindly supplied by Milupa AG (Fridrichsdorf, Germany). It is used as the protein/peptid component of various hypoantigenic infant formulas. The method of manufacturing casein hydrolysate is not known to us as it is a subject of commercial secret. All substances were stored at -20 °C.
Casein hydrolysate separation
The casein hydrolysate fractions were obtained by separation and isolation of the casein hydrolysate according to their molecular weights by fast protein liquid chromatography (FPLC system; Pharmacia Freiburg, Germany), in connection with a gel permeation column (Superdex 75 HR 10/30; Pharmacia Freiburg, Germany). The casein hydrolysate was dissolved (10 mg/ml) in deionized water, filtered and 100 µl (1000 µg) was run through the column, then eluted with Tris-NaCl buffer (Tris-HCl 10 mM; NaCl 100 mM; SDS 0.1%; pH 6.8). The UV absorption was continually measured at 280 nm. The fractions were collected, freeze-dried and stored at -20 °C. The FPLCanalyses were carried out in the Research Institute for Child Nutrition, Dortmund, Germany.
ELISA IgG-binding assay
A modification of a standard method (Firer et al. 1981 ) was used. ELISA high affinity plates (Greiner, Kremsmünster, Austria) were pretreated with 5 % v/v glutaraldehyde/carbonate buffer (Na 2 CO 3 15 mM; NaHCO 3 35 mM; pH 9.5) solution for three hours. The respective antigens in the quantity of 4 µg (100 µl of 40 µg/ml dilution) of protein/peptide equivalent, were dissolved in the same carbonate buffer and incubated at 4 °C overnight. After washing with Tris buffered saline (TBS) (Tris-HCl 50 mM; NaCl 150 mM; Tween 20: 0.5%; pH 7.5) blocking of unspecific binding sites with 1% human serum albumin (HSA) (Behring, Germany) in TBS (HSA-TBS) was performed for 1 h. Test sera diluted 1:400 (1:200) in HSA-TBS were incubated at 4 °C overnight. As higher concentration of antibodies is necessary to bind to peptides, for assays with casein hydrolysate peptide fractions, only sera of milk intolerant patients were used and these were diluted 1:200. After washing, incubation with 1:2000 in HSA-TBS diluted alkaline phosphatase-labelled goat anti-human IgG antibody (ACCU-SPECS, Westbury, NY, USA), was performed for 2 h. Final IgG binding was visualized with p-nitrophenyl phosphate (St. Louis, USA). The enzymatic reaction was stopped by adding 200 mM hydrochloric acid after 20 min and the absorbance was measured at 405 nm with an ELISA reader.
Results

Antigenicity of casein and casein fractions
The average binding capacity of the patient sera to various cow milk antigens compared to the pooled serum of asymptomatic individuals is shown in Fig. 1 .
The high binding capacity of cow milk is probably due to the relatively high content of caseins. Casein possesses even higher antigenicity than the corresponding amount of whole cow milk. The strongest difference in binding capacity between the test sera and standard serum was seen in κ-casein (approx. 8-fold rise); it was also the most antigenic fraction out of all casein fractions. There was a substantial difference between the industrially separated 90% pure β-casein (B-casein-S) and the β-casein (b-casein) separated with anion exchange chromatography. This could be explained by the possible presence of another casein fraction with a higher antigenicity. Furthermore a reduced IgG binding of dephosphorylated α-casein compared to native α-casein was found.
Antigenicity of the casein hydrolysate and its peptide fractions
The IgG binding capacity of the whole casein hydrolysate compared to those of cow milk and the whole casein is demonstrated in Fig. 2. A strong antigenicity was seen in cow milk and the whole casein (more than 3fold to control serum; for casein: optical density 2.00 in patient sera versus 0.67 in control sera). The casein hydrolysate shows only about 18.5% of casein antigenicity (optical density 0.37 versus 2.00). Almost no difference was seen between patient and control sera in casein hydrolysate IgG binding.
The results of the liquid chromatographic analysis of the casein hydrolysate and the IgG binding capacity of the casein hydrolysate fragments with known molecular weight are shown in Figs 3 and 4 , respectively. Considering the molecular weight pattern of the investigated hydrolysate, 99% of the peptide fragments have a molecular weight lower than 9.2 kDa and more than 80% lower than 8.4 kDa. The antigenicity of particular fractions ranged from 44.6% (fraction 1) down to 24.6% (fraction 8) of the binding capacity of the whole casein hydrolysate. None of the fractions reached the antigenicity value of the whole casein hydrolysate.
Discussion
Cow milk is a mixture of proteins, about 80% of which are caseins. Caseins from cow milk form an inhomogenous group of proteins with fibrilar structure consisting of 4 major fractions: α s1 -, α s2 -caseins, β-and κ-each forming about 45, 10, 34 and 11 % of the whole casein amount respectively (Alais and Blanc 1975) Production of anti-cow milk IgG antibodies represents a normal response of an organism to cow milk antigens and is dependent on the diet Lessof et al. 1991) . After an initial peak in the generation of milk specific IgG, these levels remain relatively stable after the 9th month of age in individuals with milk diet (Tainio et al. 1988; Müller 1988) . However, its level is markedly increased in some pathological conditions like inflammatory bowel disease, coeliac disease, cow milk sensitive enteropathy (Firer et al. 1987; Lerner et al. 1989 ) and also eczema (Firer et al. 1982) .
The investigated sera recognized most of the antigenic sites of bovine κ-casein. The epitope structure of this casein fraction has been reported to differ significantly from those of human κ-casein (Otani et al. 1991) . Thus, it represents one of the strongest immunogens in bovine milk. On the contrary, bovine β-casein was found to have a sequence homology of 47 % with human β-casein (Otani et al. 1988 ). This antigenic similarity might, to some extent, explain the reduced binding capacity for human IgG antibodies.
As reported by H eine et al. (1989) , processing milk proteins by desialization and/or dephosphorylation changes their immunologic properties. Thus, a decreased IgG binding of dephosphorylated α-casein confirms not only the reduction of antigen binding capacity, but also suggests a decline of antigenicity.
Mind the difference in antigenicity of particular casein fractions between sera of healthy controls and those of patients with cow milk intolerance. The sera of healthy controls Fig. 4 . IgG binding capacity of casein hydrolysate fractions of diverse molecular weights compared to those of casein hydrolysate and cow milk (absorbance values of the respective test sera mean ± standard deviation are given at 1:200 sera dilution, the value for cow milk was calculated by extrapolation). The numbers of each fraction refer to the FPLC-chromatogram.
recognized mostly epitopes in B-casein-S, and to a lesser extent those of κ-casein and β-casein. Interestingly, milk intolerant infants generated IgG-antibodies mostly to κ-casein and B-casein-S. It may be thinkable that κ-casein be differently processed by antigen presentation cells and presented to immunocompetent cells in the gut associated lymphatic tissue of milk intolerant infants. This may lead to enhanced systemic production of specific IgG antibodies to this casein fraction. The difference between antigenicity of commercial B-casein-S (Sigma) and that of chromatographically purified β-casein may have arisen due to different isolation process of this fraction from whole casein.
The procedures to reduce the antigenicity of milk proteins are heat treatment, which reduces the amount of conformational epitopes in globular proteins, and enzymatic hydrolysis, where cleavage of the protein´s primary structure occurs (L e e 1992). The antigenicity (Fallstrom et al. 1986; Gortler and Urbanek 1990; Leary, Jr. 1992; Wahn et al. 1992 ) and immunogenicity (Stephan et al. 1990; Cordle et al. 1991) of protein hydrolysates and milk proteins (Wahn et al. 1981) have recently been studied in animal and human models. These studies demonstrated a decreasing antigenicity with the increasing degree of hydrolysis due to the reduction of epitopes. Moreover, peptides from hydrolysed milk show both reduced immunogenicity (Cordle et al. 1991 ) and seem to induce oral tolerance without elicitating antibody response (Enomoto et al. 1993) . However, despite of excessive hydrolysis, intact cow milk proteins may persist in hypoantigenic formulae mostly in low degree hydrolysates (M akinen-Kiljunen and Sorva 1993) and elicit severe clinical reactions in highly sensitized individuals (Ellis et al. 1991; Saylor and Bahna 1991) .
Although there is a solid evidence on the usefulness of hydrolysate formulae, it is not known by now, what degree of hydrolysis is necessary to obtain the desired reduction of antigenicity and what peptide fractions are responsible for the residual antigenicity of the hydrolysate.
The antigenicity of whole casein hydrolysate represented about 18 % of that of cow milk. As there are only traces of fragments with a molecular weight higher than 10 kDa present in the investigated hydrolysate, the hydrolysate can be labelled as partially hydrolysed with relative high residual antigenicity.
The molecular weight of the FPLC-fraction with the highest antigenicity (fraction 1) ranged over 14.8 kDa. However, from the quantitative point of view, it represents a very small fraction. On the other hand, the peptide fraction with the lowest antigenicity belonged to the 6.5 -3.5 kDa range. As we used peptides to recognize the antibody generated by the entire protein molecule, it can be assumed that if these fragments bind to the IgG protein antibodies, they probably contain epitopes of the whole protein. The smallest peptide that still possesses some residual antigenic reactivity represents the epitope; in general it corresponds to a size of 5-7 amino acid residues (Regenmortel van 1988) . The differences in antigenicity between particular hydrolysate fractions were negligible and none of the fractions reached the antigenicity of the whole casein hydrolysate. This can be partly explained by altered aggregation and immunologic behaviour of peptides in the entire hydrolysate mixture tending to form macromolecular complexes.
In infants with high risk of developing an atopic disease, preventive measures such as dietary prophylaxis with breast feeding or hydrolysed formulae are recommended. Milk processing as the enzymatic hydrolysis of casein does reduce the capacity of casein peptides to bind to specific antibodies. The identification of hydrolysate fractions with highest antigenicity by specific antibody binding assays appears to be a useful tool for in vitro characterization of cow milk hydrolysates.
Antigenicita kaseinÛ kravského mléka, kaseinového hydrolyzátu a frakcí kaseinového hydrolyzátu
Kasein kravského mléka obsahuje nûkolik frakcí. KaÏdá znich má rÛznou strukturu a rÛznou antigenicitu. Cílem práce bylo stanovit vazebnou kapacitu kaseinu kravského mléka, kaseinov˘ch fakcí, kaseinového hydrolyzátu a jeho peptidov˘ch frakcí pro lidské protilátky tfiídy IgG (antigenicitu).
Nativní kravské mléko, bovinní kasein, α-kasein nativní i defosforylovan˘, β-a κ-kasein, dále kaseinov˘ hydrolyzát a jeho frakce byly inkubovány se séry 5 pacientÛ trpících intolerancí kravského mléka a se sebran˘m kontrolním sérem od zdrav˘ch jedincÛ pijících kravské mléko. Vazba protilátek tfiídy IgG byla vy‰etfiena metodou ELISA.
U zdrav˘ch kontrol mûly nejvy‰‰í antigenicitu β-kaseiny (komerãní i chromatograficky izolovan˘). U jedincÛ s intolerancí kravského mléka byly nejsilnûj‰ími antigeny κ-kasein souãas-nû s β-kaseiny. Antigenicita kaseinového hydrolyzátu ve srovnání s nehydrolyzovan˘m kaseinem byla sníÏena na 18,5 % u pacientÛ a na 41,8% u zdrav˘ch kontrol. V hydrolyzátu byly chromatograficky nalezeny stopy intaktních bílkovin. Antigenicita jednotliv˘ch frakcí kaseinového hydrolyzátu dosahovala od 24% do 44% antigenicity celého hydrolyzátu. Aãkoliv antigenicita frakcí pfiibliÏnû korelovala s jejich molekulovou hmotností, rozdíly v antigenicitû mezi jednotliv˘mi frakcemi byly zanedbatelné.
Beta-kasein byl nejsilnûj‰ím antigenem u zdrav˘ch kontrol, zatímco kapa-kasein pfiedstavuje siln˘ antigen u jedincÛ s intolerancí kravského mléka. Kaseinov˘ hydrolyzát je pro pacienty s intolerancí kravského mléka pfiibliÏnû pûtkrát ménû antigenní ve srovnání s nehydrolyzovan˘m kaseinem. Antigenicita hydrolyzátov˘ch frakcí byla niÏ‰í neÏ antigenicita celé-ho hydrolyzátu. Identifikace kaseinÛ a jejich frakcí s nejvy‰‰í vazebnou kapacitou pro lidské protilátky tfiídy IgG je dÛleÏitá pro v˘robu kojeneck˘ch mléãn˘ch pfiípravkÛ se sníÏe-nou antigenicitou zaloÏen˘ch na kaseinov˘ch hydrolyzátech.
